Slideshow

New FDA Warning

Author(s):

James Phelps, MD

A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.

Related Videos
World Bipolar Day
bipolar
bipolar
bipolar
journey
Related Content
pills
April 30th 2025

April in Review: Updates on the Psychiatric Treatment Pipeline

Leah Kuntz
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar disorder
April 7th 2025

Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment

Grace Koennecke
Four Myths About Lamotrigine
August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
March 14th 2025

How to Decide Whether Depressions Are Bipolar Depressions

David N. Osser, MD
bipolar
March 4th 2025

BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.